BRAF and RAS mutations in human lung cancer and melanoma

Cancer Research

Volumn 62, Issue 23, 2002, Pages 6997-7000

  Brose, Marcia S ^a   Volpe, Patricia ^a   Feldman, Michael ^b   Kumar, Madhu ^a   Rishi, Irum ^a   Gerrero, Renee ^a   Einhorn, Eugene ^c   Herlyn, Meenhard ^c   Minna, John ^e   Nicholson, Andrew ^f   Roth, Jack A ^g   Albelda, Steven M ^a   Davies, Helen ^d   Cox, Charles ^d   Brignell, Graham ^d   Stephens, Philip ^d   Andrew Futreal, P ^d   Wooster, Richard ^d   Stratton, Michael R ^d   Weber, Barbara L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c WISTAR INSTITUTE   (United States)

^d WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^f ROYAL BROMPTON HOSPITAL   (United Kingdom)

^g UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE; PROTEIN KINASE BRAF; RAS PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CODON; CONFORMATION; CONTROLLED STUDY; DNA SCREENING; ENZYME ACTIVATION; EXON; GENE MUTATION; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MELANOMA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

CARCINOMA, NON-SMALL-CELL LUNG; CODON; GENES, RAS; HUMANS; LUNG NEOPLASMS; MAP KINASE SIGNALING SYSTEM; MELANOMA; MITOGEN-ACTIVATED PROTEIN KINASES; MUTATION; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS C-RAF; TUMOR CELLS, CULTURED;

EID: 0036894746     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Adjei, A. A. Blocking oncogenic Ras signaling for cancer therapy. J. Natl. Cancer Inst., 93: 1062-1074, 2001.
2. Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., Davis, N., Dicks, E., Ewing, R., Floyd, Y., Gray, K., Hall, S., Hawes, R., Hughes, J., Kosmidou, V., Menzies, A., Mould, C., Parker, A., Stevens, C., Watt, S., Hooper, S., Wilson, R., Jayatilake, H., Gusterson, B. A., Cooper, C., Shipley, J., Hargrave, D., Pritchard-Jones, K., Maitland, N., Chenevix-Trench, G., Riggins, G. J., Bigner, D. D., Palmieri, G., Cossu, A., Flanagan, A., Nicholson, A., Ho, J. W., Leung, S. Y., Yuen, S. T., Weber, B. L., Seigler, H. F., Darrow, T. L., Paterson, H., Marais, R., Marshall, C. J., Wooster, R., Stratton, M. R., and Futreal, P. A. Mutations of the BRAF gene in human cancer. Nature, 417: 949-954, 2002.
3. Rajagpalan, H., Bardelli, A., Lengauer, C., Kinzler, K., Vogelstein, B., and Velculescue, V. RAF/RAS oncogenes and mismatch-repair status. Nature, 418: 934, 2002.
4. Muneer, S. (ed.). MAP Kinase and PP2A in Cancer Pathogenesis. Dallas, TX: University of Texas Southwestern Medical Center, 2002.
5. Satyamoorthy, K., Li, G., Gerrero, M. R., Brose, M. S., Weber. B. L., van Belle, P., Elder, D. E., and Herlyn, M. Constitutive MAP Kinase Activation in Melanoma is Mediated by BRAF Mutations and Autocrine Growth Factor Stimulation, submitted for publication, 2002.
6. Chamberlain, J. S., Boehnke, M., Frank, T. S., Kiousis, S., Xu, J., Guo, S. W., Hauser, E. R., Norum, R. A., Helmbold, E. A., Markel, D. S., et al. BRCA1 maps proximal to D17S579 on chromosome 17q21 by genetic analysis. Am. J. Hum. Genet., 52: 792-798, 1993.
7. Guan, K. L., Figueroa, C., Brtva, T. R., Zhu, T., Taylor. J., Barber, T. D., and Vojtek, A. B. Negative regulation of the serine/threonine kinase B-Raf by Akt. J. Biol. Chem., 275: 27354-27359, 2000.
8. Zimmermann, S., and Moelling, K. Phosphorylation and regulation of Raf by Akt (protein kinase B). Science, 286: 1741-1744, 1999.
9. Obata, T., Yaffe, M. B., Leparc, G. G., Piro, E. T., Maegawa, H., Kashiwagi, A., Kikkawa, R., and Cantley, L. C. Peptide and protein library screening defines optimal substrate motifs for AKT/PKB. J. Biol. Chem., 275: 36108-36115, 2000.
10. Chong, H., Lee, J., and Guan, K. L. Positive and negative regulation of Raf kinase activity and function by phosphorylation. EMBO J., 20: 3716-3727, 2001.
11. Rodenhuis, S., Slebos, R. J., Boot, A. J., Evers, S. G., Mooi, W. J., Wagenaar, S. S., van Bodegom, P. C., and Bos, J. L. Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. Cancer Res., 48: 5738-5741, 1988.
12. Ferretti, G., Curigliano, G., Pastorino, U., Cittadini, A., Flamini, G., Calabro, M. G., De Pas, T., Orlando, L., Mandala, M., Colleoni, M., Spaggiari, L., Granone, P. L., Pagliari, G., de Braud, F., Fazio, N., and Goldhirsch, A. Detection by denaturant gradient get electrophoresis of tumor-specific mutations in biopsies and relative bronchoalveolar lavage fluid from resectable non-small cell lung cancer. Clin. Cancer Res., 6: 2393-2400, 2000.
13. Vahakangas, K. H., Bennett, W. P., Castren, K., Welsh, J. A., Khan, M. A., Blomeke, B., Alavanja, M. C., and Harris, C. C. p53 and K-ras mutations in lung cancers from former and never-smoking women. Cancer Res., 61: 4350-4356, 2001.
14. Slebos, R. J., Hruban, R. H., Datesio, O., Mooi, W. J., Offerhaus, G. J., and Rodenhuis, S. Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung. J. Natl. Cancer Inst., 83: 1024-1027, 1991.
15. Griffey, S. M., Kraegel, S. A., and Madewell, B. R. Rapid detection of K-ras gene mutations in canine lung cancer using single-strand conformational polymorphism analysis. Carcinogenesis, 19: 959-963. 1998.
16. Tsao, H., Zhang, X., Fowlkes, K., and Haluska, F. G. Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines. Cancer Res., 60: 1800-1804, 2000.